FindTrial
Sign In

Constructing nomograms for intraoperative prediction of occult nodal metastasis in clinical stage IA lung adenocarcinoma

Constructing nomograms for intraoperative prediction of occult nodal metastasis in clinical stage IA lung adenocarcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200061299
Enrollment
Unknown
Registered
2022-06-19
Start date
2012-04-01
Completion date
Unknown
Last updated
2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Group 1 :constructing nomograms
Group 2:validating nomograms

Sponsors

Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Clinical stage IA lung adenocarcinoma based on CT scan; 2. Except for pure ground-glass opacity (pGGO) lesions, adenocarcinoma in situ (AIS) or minimally invasive adenocarcinoma (MIA), all patients required lobectomy and systematic lymph node dissection.

Exclusion criteria

Exclusion criteria: 1. Patients with CT scan tumor > 3 cm or mediastinal lymph node enlargement; 2. Patients who have received neoadjuvant therapy; 3. Patients with multiple pulmonary nodules.

Design outcomes

Primary

MeasureTime frame
probability of occult nodal metastasis;—

Countries

China

Contacts

Public ContactYousheng Mao

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

youshengmao@gmail.com+86 10 87787150

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026